This SLR identified only one study formally assessing treatment sequencing (RECAP), in which no significant difference in kidney outcomes was observed, based on whether SGLT2i or GLP-1 RA therapy was initiated first [17]
This demonstrates that GLP-1R agonism also regulates (mostly reducing) ethanol-metabolizing genes, which are independent of ethanol intake
Improved Mood and Mental Clarity: Our injections contribute to better brain health and emotional well-being, helping you maintain a positive outlook on your weight loss journey
GLP-1 therapy restores "normal fullness" and food peace
The field now needs to focus on understanding those processes in much greater detail and developing treatments that can be used together to tackle the disease from multiple angles. Susan Kohlhaas, PhD Experts who were not involved in the trials spoke to Medical News Today about their feelings concerning the findings
These medications slow gastric emptying to help control blood glucose and appetite, but this delayed digestion can increase gas formation, including hydrogen sulfide